U U.S. News Guest Feb 3, 2026 #1 The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December. Continue reading...
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December. Continue reading...